Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
293780.KQ Stock Summary
Top 10 Correlated ETFs
293780.KQ
In the News
293780.KQ Financial details
Company Rating
Sell
Market Cap
138.48B
Income
-19.1B
Revenue
323.87M
Book val./share
2436.32
Cash/share
2371.66
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Jan 2023
P/E
-16.63
Forward P/E
-
PEG
-2.06
P/S
3567.74
P/B
4.04
P/C
2.93
P/FCF
-23.12
Quick Ratio
10.11
Current Ratio
13.13
Debt / Equity
0.25
LT Debt / Equity
0.25
-
-
EPS (TTM)
-856.45
EPS next Y
-
EPS next Q
-
EPS this Y
80.69%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
24.24%
Revenue last 5Y
-20.48%
Revenue Q/Q
3348.52%
EPS Q/Q
99.26%
-
-
-
-
SMA20
-3.2%
SMA50
-22.77%
SMA100
-17.57%
Inst Own
-
Inst Trans
-
ROA
-22%
ROE
-23%
ROC
-0.2%
Gross Margin
91%
Oper. Margin
-19558%
Profit Margin
-22309%
Payout
-
Shs Outstand
22.3M
Shs Float
14.6M
-
-
-
-
Target Price
-
52W Range
4935.0-13650.0
52W High
-49.16%
52W Low
+40.63%
RSI
60.83
Rel Volume
0.71
Avg Volume
150.01K
Volume
106.69K
Perf Week
14.52%
Perf Month
-2.53%
Perf Quarter
-22.28%
Perf Half Y
-23.48%
-
-
-
-
Beta
2.033
-
-
Volatility
322.64%, 653.33%
Prev Close
-2.39%
Price
6940
Change
2.81%
293780.KQ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 46.8 | 15.48 | 14.89 | 2.17 | 14.52 | |
Net income per share | -289.38 | -177.89 | -711.76 | -473.98 | -856.45 | |
Operating cash flow per share | -275.78 | -171.83 | -592.45 | -306.55 | -632.1 | |
Free cash flow per share | -447.61 | -266.09 | -603.71 | -359.78 | -639.61 | |
Cash per share | 2.12K | 1.94K | 1.53K | 762.48 | 2.37K | |
Book value per share | 3.45K | 3.27K | 4.11K | 2.35K | 2.44K | |
Tangible book value per share | 3.45K | 3.27K | 4.1K | 2.35K | 2.44K | |
Share holders equity per share | 3.45K | 3.27K | 4.11K | 2.35K | 2.44K | |
Interest debt per share | 1.26 | 1.29 | 3.76 | 5.12 | 667.45 | |
Market cap | 879.24B | 889.99B | 558.66B | 231.81B | 202.47B | |
Enterprise value | 862.73B | 875.37B | 552.2B | 229.19B | 190.39B | |
P/E ratio | -139.61 | -227.1 | -52.26 | -21.94 | -10.6 | |
Price to sales ratio | 863.21 | 2.61K | 2.5K | 4.79K | 625.17 | |
POCF ratio | -146.49 | -235.11 | -62.79 | -33.93 | -14.36 | |
PFCF ratio | -90.26 | -151.83 | -61.62 | -28.91 | -14.2 | |
P/B Ratio | 11.7 | 12.35 | 9.06 | 4.43 | 3.73 | |
PTB ratio | 11.7 | 12.35 | 9.06 | 4.43 | 3.73 | |
EV to sales | 847 | 2.57K | 2.47K | 4.74K | 587.87 | |
Enterprise value over EBITDA | -122.28 | -151.02 | -50.1 | -25.4 | -11.63 | |
EV to operating cash flow | -143.74 | -231.25 | -62.06 | -33.54 | -13.51 | |
EV to free cash flow | -88.56 | -149.33 | -60.91 | -28.58 | -13.35 | |
Earnings yield | -0.01 | 0 | -0.02 | -0.05 | -0.09 | |
Free cash flow yield | -0.01 | -0.01 | -0.02 | -0.03 | -0.07 | |
Debt to equity | 0 | 0 | 0 | 0 | 0.25 | |
Debt to assets | 0 | 0 | 0 | 0 | 0.15 | |
Net debt to EBITDA | 2.34 | 2.52 | 0.59 | 0.29 | 0.74 | |
Current ratio | 63.99 | 54.6 | 30.19 | 19.63 | 70.27 | |
Interest coverage | -3.52K | -2.63K | -6.19K | -2.11K | -14.26 | |
Income quality | 0.95 | 0.97 | 0.83 | 0.65 | 0.74 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.05 | 0.17 | 0.36 | 2.09 | 0 | |
Research and developement to revenue | 5.36 | 11.23 | 40.59 | 128.16 | 38.23 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.62 | 0.55 | 0.02 | 0.17 | 0.01 | |
Capex to revenue | -3.67 | -6.09 | -0.76 | -24.53 | -0.52 | |
Capex to depreciation | -39.16 | -8.31 | -0.53 | -2.58 | -0.33 | |
Stock based compensation to revenue | 0.48 | 0.53 | 0.61 | 2.56 | 0 | |
Graham number | 4.74K | 3.62K | 8.11K | 5.01K | 6.85K | |
ROIC | -0.1 | -0.08 | -0.18 | -0.18 | -0.32 | |
Return on tangible assets | -0.08 | -0.05 | -0.16 | -0.19 | -0.21 | |
Graham Net | 2.03K | 1.81K | 1.33K | 699.98 | 754.28 | |
Working capital | 46.04B | 42.94B | 22.99B | 19.38B | 56.66B | |
Tangible asset value | 75.14B | 71.99B | 61.62B | 52.33B | 54.33B | |
Net current asset value | 44.52B | 40.34B | 20.53B | 16.67B | 19.28B | |
Invested capital | 0 | 0 | 0 | 0 | 0.25 | |
Average receivables | 0 | 522.57M | 601.52M | 1.82B | 2.98B | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0.5 | 0.5 | |
Days sales outstanding | 122.82 | 751.73 | 816.97 | 23.66K | 3.19K | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 2.97 | 0.49 | 0.45 | 0.02 | 0.11 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 11.15M | 0 | |
ROE | -0.08 | -0.05 | -0.17 | -0.2 | -0.35 | |
Capex per share | -171.83 | -94.26 | -11.26 | -53.22 | -7.51 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.8 | 0.87 | 0.3 | 0.38 | 12.97 | |
Net income per share | -115.11 | -200.39 | -96.51 | -186.98 | -372.57 | |
Operating cash flow per share | -89.76 | -138.36 | -57.25 | -79.6 | -356.89 | |
Free cash flow per share | -111.9 | -140.54 | -59.69 | -86.05 | -353.33 | |
Cash per share | 762.16 | 513.05 | 843.67 | 3.11K | 2.37K | |
Book value per share | 2.35K | 2.15K | 2.05K | 2.87K | 2.44K | |
Tangible book value per share | 2.35K | 2.15K | 2.05K | 2.87K | 2.44K | |
Share holders equity per share | 2.35K | 2.15K | 2.05K | 2.87K | 2.44K | |
Interest debt per share | 5 | 5.34 | 5.13 | 765.61 | 651.85 | |
Market cap | 231.91B | 229.9B | 199.8B | 206.71B | 202.47B | |
Enterprise value | 229.29B | 223.88B | 194.11B | 190.08B | 190.39B | |
P/E ratio | -22.59 | -12.86 | -23.21 | -12.39 | -6.09 | |
Price to sales ratio | 12.96K | 11.8K | 29.45K | 24.65K | 700.09 | |
POCF ratio | -115.87 | -74.52 | -156.51 | -116.45 | -25.44 | |
PFCF ratio | -92.94 | -73.36 | -150.1 | -107.73 | -25.7 | |
P/B Ratio | 4.43 | 4.79 | 4.37 | 3.23 | 3.73 | |
PTB ratio | 4.43 | 4.79 | 4.37 | 3.23 | 3.73 | |
EV to sales | 12.82K | 11.49K | 28.61K | 22.67K | 658.32 | |
Enterprise value over EBITDA | -90.43 | -64.67 | -67.66 | -46.54 | -32 | |
EV to operating cash flow | -114.56 | -72.57 | -152.06 | -107.09 | -23.92 | |
EV to free cash flow | -91.89 | -71.44 | -145.82 | -99.07 | -24.16 | |
Earnings yield | -0.01 | -0.02 | -0.01 | -0.02 | -0.04 | |
Free cash flow yield | -0.01 | -0.01 | -0.01 | -0.01 | -0.04 | |
Debt to equity | 0 | 0 | 0 | 0.26 | 0.25 | |
Debt to assets | 0 | 0 | 0 | 0.17 | 0.15 | |
Net debt to EBITDA | 1.03 | 1.74 | 1.98 | 4.07 | 2.03 | |
Current ratio | 19.63 | 13.13 | 15.65 | 21.95 | 70.27 | |
Interest coverage | -1.58K | -1.21K | -1.05K | -12.3 | -7.27 | |
Income quality | 0.78 | 0.69 | 0.59 | 0.43 | 0.96 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 1.73 | 1.63 | 0 | 0 | 0 | |
Research and developement to revenue | 92.1 | 131.43 | 260.38 | 389.34 | 16.55 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.25 | 0.02 | 0.04 | 0.08 | -0.01 | |
Capex to revenue | -27.6 | -2.5 | -8.04 | -17.13 | 0.27 | |
Capex to depreciation | -3.93 | -0.36 | -0.44 | -1.17 | 0.64 | |
Stock based compensation to revenue | 1.72 | 1.87 | 0 | 0 | 0 | |
Graham number | 2.47K | 3.12K | 2.11K | 3.48K | 4.52K | |
ROIC | -0.05 | -0.07 | -0.06 | -0.05 | -0.19 | |
Return on tangible assets | -0.05 | -0.09 | -0.04 | -0.04 | -0.09 | |
Graham Net | 699.69 | 441.38 | 737.66 | 1.54K | 754.28 | |
Working capital | 19.38B | 13.75B | 20.15B | 68.72B | 56.66B | |
Tangible asset value | 52.33B | 47.98B | 45.74B | 64.03B | 54.33B | |
Net current asset value | 16.67B | 10.92B | 17.24B | 35.11B | 19.28B | |
Invested capital | 0 | 0 | 0 | 0.26 | 0.25 | |
Average receivables | 2.48B | 3.14B | 2.85B | 2.53B | 2.67B | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0.5 | 1 | 0.5 | 0 | 0 | |
Days sales outstanding | 15.77K | 14.54K | 33.9K | 26.95K | 882.2 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.01 | 0.01 | 0 | 0 | 0.1 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 1.21M | 3.75M | 0 | 0 | 0 | |
ROE | -0.05 | -0.09 | -0.05 | -0.07 | -0.15 | |
Capex per share | -22.14 | -2.18 | -2.45 | -6.44 | 3.56 |
293780.KQ Frequently Asked Questions
What is AptaBio Therapeutics Inc. stock symbol ?
AptaBio Therapeutics Inc. is a KR stock and trading under the symbol 293780.KQ
What is AptaBio Therapeutics Inc. stock quote today ?
AptaBio Therapeutics Inc. stock price is $6940 today.
Is AptaBio Therapeutics Inc. stock public?
Yes, AptaBio Therapeutics Inc. is a publicly traded company.